Safety data across larger populations TRIUMPH-4 enrolled a specific population (obesity with knee osteoarthritis)
The goal is better metabolic health, better function, and a body that can sustain the result
Food and Drug Administration is cracking down on telehealth companies for making false and misleading claims about compounded versions of popular weight loss drugs, GLP-1s
When assessing individual adverse events, acute pancreatitis, AKI, and malignant neoplasm were among the most reported across the 4 RCTs
abdomen, thigh, or, if someone else is giving your injection, back of your upper arm)
Which options are available to you depends on your state and what the provider determines is appropriate